Global Infection Control and Biosafety Products Market Growth (Status and Outlook) 2023-2029

Global Infection Control and Biosafety Products Market Growth (Status and Outlook) 2023-2029

Infection control is the discipline concerned with preventing nosocomial or healthcare-associated infection. Infection control addresses factors related to the spread of infections within the healthcare setting (whether patient-to-patient, from patients to staff and from staff to patients, or among-staff), including prevention (via hand hygiene/hand washing, cleaning/disinfection/sterilization, vaccination, surveillance), monitoring/investigation of demonstrated or suspected spread of infection within a particular health-care setting (surveillance and outbreak investigation), and management (interruption of outbreaks).

LPI (LP Information)' newest research report, the “Infection Control and Biosafety Products Industry Forecast” looks at past sales and reviews total world Infection Control and Biosafety Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Infection Control and Biosafety Products sales for 2023 through 2029. With Infection Control and Biosafety Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infection Control and Biosafety Products industry.

This Insight Report provides a comprehensive analysis of the global Infection Control and Biosafety Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infection Control and Biosafety Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infection Control and Biosafety Products market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infection Control and Biosafety Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infection Control and Biosafety Products.

The global Infection Control and Biosafety Products market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Anti-infective agents include antibiotics, antibacterials, antifungals, antivirals and antiprotozoals.

This report presents a comprehensive overview, market shares, and growth opportunities of Infection Control and Biosafety Products market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Biosafety Products
Infection Control Products

Segmentation by application
Children
Adults

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3M
Reckitt Benckiser
BODE Chemie
STERIS
Thermo Fisher Scientific
ABC Compounding
American Biotech Labs
Baxter
Bio-Cide International
CareFusion
Ecolab
Hemco Corporation
Kewaunee
Labconco
Metrex Research
The Baker Company
The Clorox Company
Terra Universal

Please note: The report will take approximately 2 business days to prepare and deliver.